Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAME-05: Tenofovir Gel vs Film PK/PD
NCT02280109Phase 1Completed
- Sponsor
- CONRAD
- Start
- Nov 2014
- Primary completion
- Dec 2015
- Modality
- Implantable Devices, Transdermal Patches, Hydrogel Systems
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenofovir gel in human immunodeficiency virus infection (HIV) (2 arms), sponsored by CONRAD. Primary endpoints: Plasma tenofovir concentration-time curve (AUC0-72), PBMC tenofovir diphosphate concentration-time curve (AUC0-72) and 5 more. Started Nov 2014; status: completed.
02
Drugs
tenofovir gel
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02280109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02280109.